Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000904454-14-000416

10% owner acquired 21,250 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Domain Partners VI, L.P. 10% owner 2014-05-07 Conversion +21,250 1,973,389 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Domain Partners VI, L.P. 10% owner 2014-05-07 Conversion · Convertible Promissory Note −0 0 D: show line 2 in the form
Loading xslF345X03/edgar.xml…